An Osaka University-led research team has recently published findings that provide a ray of hope for the millions of Parkinson’s disease (PD) sufferers worldwide. Although more common in those aged over sixty, PD can strike at any age, with an estimated prevalence of 41 per 100,000 people in their forties. And while not fatal in and of itself, the progressive neurodegeneration that is characteristic of PD can often cause secondary effects that lead to death.
The exact cause of PD is still a mystery, but researchers believe that both genetics and the environment are likely to play a part. Importantly though, all PD patients show a loss of dopaminergic neurons in the brain and increased levels of a protein called ?-synuclein, which accumulates in Lewy bodies. Lewy bodies are a pathological feature of both familial and sporadic forms of the disease, as well as some types of dementia.
In the study published this month in Scientific Reports, the team led by researchers from Osaka University’s Graduate School of Medicine focused on ?-synuclein as a target for a novel PD treatment.
“Although there are drugs that treat the symptoms associated with PD, there is no fundamental treatment to control the onset and progression of the disease,” explains lead author Takuya Uehara. “Therefore, we looked at ways to prevent the expression of ?-synuclein and effectively eliminate the physiological cause of PD.”
To do this, the researchers designed short fragments of DNA that are mirror images of sections of the ?-synuclein gene product. The constructs were stabilized by the addition of amido-bridging. The resulting fragments, called amido-bridged nucleic acid-modified antisense oligonucleotides (ASOs), bind to their matching mRNA sequence, preventing it from being translated into protein. After screening 50 different ASOs, the researchers settled on a 15-nucleotide sequence that decreased ?-synuclein mRNA levels by 81%.
“When we tested the ASO in a mouse model of PD, we found that it was delivered to the brain without the need for chemical carriers,” says co-lead author Chi-Jing Choong. “Further testing showed that the ASO effectively decreased ?-synuclein production in the mice and significantly reduced the severity of disease symptoms within 27 days of administration.”
Explains senior author of the study Hideki Mochizuki, “Our results showed that gene therapy using ?-synuclein-targeting ASOs is a promising strategy for the control and prevention of PD. We expect that in the future, this method will be used to not only successfully treat PD, but also dementia caused by ?-synuclein accumulation.”
Learn more: Stopping Parkinson’s disease before it starts
The Latest on: Parkinson’s disease
via Google News
The Latest on: Parkinson’s disease
- Muhammad Aunty! 74-year-old grandma in Turkey beats Parkinson’s in the boxing ringon January 17, 2021 at 4:03 am
Known as Aunty Naciye among her Turkish friends, a Belgian-born 74-year-old woman named Nancy Van Der Straeten has been fighting off Parkinson's disease with some highly impressive grandma boxing in ...
- Paul Sinha health: The Sinnerman has degenerative disease Parkinson'son January 16, 2021 at 1:00 pm
PAUL SINHA built his reputation as The Sinnerman on ITV's The Chase for the past decade. Now the broadcaster is airing his very own comedy quiz show, Paul Sinha's TV Showdown. This man isn't letting ...
- When Man With Parkinson’s Struggles To Use Pill Bottle, TikTokers Create Better One.on January 16, 2021 at 3:15 am
He also happens to be living with Parkinson’s disease. He was diagnosed with the brain disorder in 2003. Symptoms include involuntary shaking, muscle and joint stiffness, and problems with walking and ...
- Increased risk of Parkinson's disease in patients with schizophreniaon January 15, 2021 at 10:47 am
A new study conducted at the University of Turku, Finland, shows that patients with a schizophrenia spectrum disorder have an increased risk of Parkinson's disease later in life. The increased risk ...
- Discover Parkinson's Disease Drugs Market to grow at a much faster rate beyond 2020| Financial Analysis and Forecaston January 15, 2021 at 9:59 am
A recent market report printed on the Parkinson’s Disease Drugs Market presents an associate in-depth summary of the Parkinson’s Disease Drugs market. World Parkinson’s Disease Drugs research report ...
- Scientists seek insight into Parkinson’s, addiction by tracking gene expression in the brainon January 14, 2021 at 10:54 am
With grants form the Mathers Foundation, MIT neuroscientists Myriam Heiman and Alan Jasanoff will screen for genes that could help brain cells withstand Parkinson’s disease and map how gene expression ...
- MIND and Mediterranean diets correlated with later onset of Parkinson's diseaseon January 13, 2021 at 6:16 pm
A new study from UBC researchers suggests a strong correlation between following the MIND and Mediterranean diets and later onset of Parkinson's disease (PD).
- MIND and Mediterranean diets associated with later onset of Parkinson's diseaseon January 13, 2021 at 12:36 pm
A new study from UBC researchers suggests a strong correlation between following the MIND and Mediterranean diets and later onset of Parkinson's disease (PD). While researchers have long known of ...
- Vitamins C and E Tied to Lower Risk for Parkinson’s Diseaseon January 13, 2021 at 11:51 am
Consuming foods high in vitamins C and E may help protect against the onset of Parkinson’s later in life, a Swedish study suggests.
- Vitamins C and E Linked to Reduced Risk for Parkinson's Diseaseon January 12, 2021 at 1:12 pm
Higher intake of both vitamins had a stronger effect on risk than higher intake of either alone. BMI and coffee consumption also appeared to influence their effect on PD risk.
via Bing News